Health for Life in Singapore (HELIOS)
The HELIOS study is one of the four cohorts of PRECISE-SG100K, which aims to recruit 100,000 Singaporeans. The HELIOS study investigates the environmental, lifestyle and genetic factors that cause heart disease, diabetes, cancer and other chronic diseases in Singapore. The cohort includes Singaporeans or Permanent Residents aged 21 to 84 years old. From 2018 to 2022, around 10,000 participants were recruited, and recruitment is ongoing. After baseline assessments, participants are followed up through linkage to health records, with plans to also re-assess participants.
Study design
Cohort
Number of participants at first data collection
10,004 (participants as of 2022)
Recruitment is ongoing
Age at first data collection
21 - 84 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2018
Primary Institutions
Imperial College London (Imperial, ICL)
NHG Health
Nanyang Technological University (NTU)
Funders
Ministry of Health
Nanyang Technological University (NTU)
National Medical Research Council (NMRC)
National Research Foundation (NRF)
Precision Health Research, Singapore (PRECISE)
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – paper or computer assisted
- Qualitative survey
- Magnetic Resonance Imaging (MRI)
- Geographic, spatial & environmental data
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
